Current Assets تغيير تاريخ
3M USD 16.38B 181M 2023-12
Abbott USD 23.51B 872M 2023-06
AngioDynamics USD 175.48M 11.93M 2023-06
AtriCure USD 266.25M 13.53M 2023-12
Baxter International USD 9.6B 2.43B 2023-12
Becton, Dickinson and Co. USD 8.16B 520M 2023-12
Boston Scientific USD 6.5B 618M 2023-09
Cooper Companies USD 1.79B 89M 2023-12
Dexcom USD 4.43B 272.5M 2023-12
Edwards Lifesciences USD 4.04B 31.8M 2023-12
Globus Medical USD 1.92B 1.96M 2023-12
Haemonetics USD 764.98M 100.76M 2023-12
Hologic USD 3.49B 690.3M 2023-12
ICU Medical USD 1.22B 1.86M 2023-12
Insulet USD 1.58B 111.8M 2023-12
Integra LifeSciences USD 1.06B 30.81M 2023-12
J&J USD 53.7B 6.86B 2023-09
Merit Medical Systems USD 1.11B 523.15M 2023-12
Olympus JPY 921.79B 43.05B 2023-09
Pfizer USD 74.01B 665M 2023-09
STAAR Surgical USD 365.27M 18.2M 2023-12
Stryker USD 12.49B 1.44B 2023-12
Surmodics USD 86.69M 841K 2023-09
Tandem Diabetes Care USD 747.99M 10.15M 2023-12
Teleflex USD 1.41B 689.86M 2023-12
Terumo JPY 684.24B 50.56B 2023-09
Zimmer Biomet Holdings USD 4.61B 237.5M 2023-12



Merit Medical Systems أصول متداولة - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2024.